Detalhe da pesquisa
1.
Identification of DAGLA as an autoantibody target in cerebellar ataxia.
J Neurol Neurosurg Psychiatry
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663995
2.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
3.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171104
4.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
5.
Prediction of relapse activity when switching to cladribine for multiple sclerosis.
Mult Scler
; 29(1): 119-129, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894247
6.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433775
7.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
8.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800908
9.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
10.
Usefulness of serum neurofilament light in the assessment of neurologic outcome in the pediatric population: a systematic literature review.
Eur J Pediatr
; 182(5): 1941-1948, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602623
11.
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(12): 1330-1337, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261289
12.
Prediction of multiple sclerosis outcomes when switching to ocrelizumab.
Mult Scler
; 28(6): 958-969, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623947
13.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373638
14.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
15.
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.
Ann Neurol
; 88(5): 1034-1042, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799417
16.
The central vein sign in multiple sclerosis patients with vascular comorbidities.
Mult Scler
; 27(7): 1057-1065, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749948
17.
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Mult Scler
; 27(5): 755-766, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538713
18.
Determinants of therapeutic lag in multiple sclerosis.
Mult Scler
; 27(12): 1838-1851, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423618
19.
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.
BMC Neurol
; 21(1): 227, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157999
20.
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Brain
; 143(9): 2742-2756, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947619